Greece: Inventions made by Greeks abroad

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece: Inventions made by Greeks abroad

The number of international patent applications (PCT and European applications) filed before the Greek patent office as receiving office has been steadily rising over the last few years. However this is certainly not the result of an economic growth. On the contrary the country has been in recession and the market has been shrinking over the years.

The rise in the number of applications seems to be an indirect effect of the migration of Greeks abroad. With a youth unemployment rate reaching close to 50%, thousands of young, educated Greeks have left the country to work in wealthier countries, mostly in western Europe.

In cases where they are working in scientific research that may result in patent applications, there is an absolute obligation that such patent applications be filed first in Greece. According to legislation dating back to 1963 (law 4325/63) all patent applications by Greek nationals need to be first filed in Greece in order to receive a check to determine whether they are relevant to national security. Accordingly, the restrictions apply to all inventions, having no priority application filed in Greece, where the inventor or applicant is a Greek citizen, regardless of whether he or she is resident in Greece.

It is worth noting that there are no provisions to allow one to retroactively correct a mistake if such an invention was first filed abroad. There are also no provisions for obtaining a security clearance or a foreign filing licence. Breach of the obligation to first file in Greece is considered a criminal offence, which could result to imprisonment of the inventor or applicant disclosing the invention abroad. While the legal provisions have not been applied in practice, they still exist, so an applicant or inventor would need to assess the risk, in such circumstances, before making a decision to first file abroad. In order to comply with the legal requirements, the applicant can either file a Greek national application, a European application or a PCT application, filed before the Greek patent office as receiving office. Apart from these criminal sanctions, there are no implications for the validity of the patent application of a Greek applicant or inventor, first filed abroad.

kilimiris.jpg

Constantinos Kilimiris


Patrinos & Kilimiris7, Hatziyianni Mexi Str.GR-11528 AthensGreeceTel: +30210 7222906, 7222050Fax: +30210 7222889info@patrinoskilimiris.comwww.patrinoskilimiris.com

more from across site and SHARED ros bottom lb

More from across our site

David Aylen, who spent more than 20 years at Gowling WLG, has joined United Trademark and Patent Services as of counsel in the UAE
Europe is among the most lucrative legal markets for PE firms to bet on, but clients’ reactions will decide whether external investment drives success
Rulings of note covered pre-June 2023 infringements and jurisdiction over non-UPC states, while winners of Managing IP’s EMEA Awards acted in multiple cases
Jason Blair, a former special marks examiner, said Dykema’s Texas presence will help him build deeper connections with clients
Lee Curtis and Rachel Platts at HGF discuss the rise of the ‘intention economy’ and its impact on trademark law
Martin Wintermeier discusses taking a hit for clients, not letting stress get to you, and why being a criminal defence lawyer might have been fun
Exclusive data and analysis reveal why clients feel external legal teams aren’t providing business-centric advice
The head of the soft IP team at engineering group Sandvik, winner of the in-house team of the year award, reveals why a flurry of M&A activity led to a busy 2024
Lawyers at Herbert Smith Freehills outline what rights owners should be doing ahead of sweeping changes to EU design law
Deals between five more law firms and President Trump and an antitrust lawsuit against Amgen were also among the top talking points this week
Gift this article